Atlas Trials

Dwight Owen

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Dwight Owen

RecordFirmDate
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer (NCT06616623)Dwight Owen2024-12-31
PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer (NCT05234307)Dwight Owen2022-11-21
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer (NCT04919382)Dwight Owen2022-01-26
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer (NCT04919369)Dwight Owen2021-10-18
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer (NCT03728361)Dwight Owen2018-12-31
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer (NCT03463460)Dwight Owen2018-06-19

Track Dwight Owen automatically

Every clearance here is in the API, with alerts when new ones post.